Skip to main content
. 2020 Jul 7;24(Suppl 2):105–118. doi: 10.1007/s10995-020-02968-6

Table 6.

Two-stage least squares impacts of program participation on program components (“Treatment on the Treated”), instrumenting for participation using treatment status and controlling for baseline characteristics (percent, unless otherwise noted)

Program component Treatment mean Control mean Impact p-Value Adjusted p-value Sample size
In previous 12 months, exposed to information on
 Relationships 17.82 20.84 − 3.02 0.680 1.000 221
 Parenting 68.24 44.60 23.65 0.010 0.043 220
 Child health care 57.28 52.63 4.65 0.614 0.999 221
 Education related services 29.44 28.80 0.64 0.930 1.000 220
 Career Counseling or job training 18.54 22.05 − 3.51 0.624 0.976 220
 Methods of birth control 84.70 67.22 17.48 0.024 0.114 217
Percent correct on assessments of knowledge of contraception
 Condoms 58.55 61.09 − 2.54 0.470 0.920 220
 Birth control pills 45.08 55.14 − 10.06 0.050 0.144 220
 IUDs 35.38 34.87 0.51 0.904 1.000 220
 Other methods 37.11 36.70 0.41 0.923 1.000 220

Treatment and control group means are regression adjusted. Impacts on binary outcomes are estimated using a two-stage least squares model instrumenting for program participation using treatment status, with standard errors adjusted to account for heteroskedasticity. Regressions control for all baseline characteristics and stratum in addition to treatment status. All p-values are based on a two-sided test, and adjusted p-values control for the familywise error rate using the method in Hothorn et al. (2008). Sample sizes differ across outcomes due to missing outcome data. Source: Baseline survey and 12 month follow-up survey

*Significantly different from zero at the .10 level after adjusting for multiple comparisons, two-tailed test

**Significantly different from zero at the .05 level after adjusting for multiple comparisons, two-tailed test

***Significantly different from zero at the .01 level after adjusting for multiple comparisons, two-tailed test